Science

Senator Durbin Announces $250,000 Investment In Chicago Clean Energy Sector To Spur Innovation And Development

WASHINGTON, D.C. –-(ENEWSPF)–March 30, 2015.  U.S. Senator Dick Durbin (D-IL) today announced that the U.S. Department of Commerce’s (DOC) Economic Development Administration (EDA) has awarded a $250,000 grant to the Clean Energy Trust (CET) in Chicago, Illinois to help spur entrepreneurship and boost economic development. In 2014, Durbin wrote a[Read More…]

Deputy UN Chief Calls for ‘Hydro-diplomacy’ as World Faces Growing Water Shortages

Photo: UNICEF/Wathiq Khuzaie GENEVA–(ENEWSPF)–30 March 2015 – The international community must gear up for a new era of “hydro-diplomacy” as the threat of water scarcity risks plunging the world into a period of geopolitical tension and stunted development, United Nations Deputy Secretary-General Jan Eliasson told delegates gathered at the General[Read More…]

Common Herbicides Linked to Antibiotic Resistance

Washington, DC–(ENEWSPF)–March 30, 2015. Last week, following the World Health Organization’s (WHO) declaration that glyphosate is carcinogenic to humans based on animal studies, a new study was published in the American Society of Microbiology’s journal, mBio, linking glyphosate, 2,4-D and dicamba to antibiotic resistance after testing the sub-lethal effects of these[Read More…]

Ebola in West Africa: The Importance of ‘Getting to Zero’

Despite progress, the region remains vulnerable to resurgence of Ebola Atlanta, GA–(ENEWSPF)–March 27, 2015.  One year after the Centers for Disease Control and Prevention began the largest international emergency response in agency history, the goal is the same: Get to zero new Ebola cases in West Africa. In a digital[Read More…]

Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial

Liberia–U.S. partnership planning Phase 3 trial and study of Ebola survivors Bethesda, Maryland–(ENEWSPF)–March 27, 2015.  Two experimental Ebola vaccines appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)[Read More…]

Most read stories this week

Take a Survey

ARCHIVES